Ori Spotlight

Ori Biotech
  • 0.0 (0)
  • 生命科学
  • 一月一更

Ori Spotlight covers the latest in cell and gene therapy. Jason C. Foster, Ori Biotech CEO will be talking to leaders from across the industry to find out more about how we can break down the barriers and seize the opportunities to make sure that every patient has access to life-changing treatments. Connect with Ori Biotech to learn more about partnering to pioneer innovative technologies in CGT manufacturing that bring CGT products to market at commercial scale at decreased costs while increasing throughput and improving quality: www.oribiotech.com/connect

  1. Warner Biddle: Building a commercial model for CAR-T in autoimmune care

    9月2日

    Warner Biddle: Building a commercial model for CAR-T in autoimmune care

    In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Warner Biddle, CEO of Kyverna Therapeutics, to explore how autologous CAR-T therapies can be delivered safely, efficiently, and at scale in autoimmune disease. Warner shares Kyverna’s approach to designing a commercially viable treatment model — one that prioritizes outpatient care, streamlined manufacturing, and real-world practicality. They discuss what it means to bring complex therapies into community settings, how Kyverna is tailoring its rollout strategy by indication, and why the future of CAR-T in autoimmune disease depends as much on delivery as it does on data. Connect with Warner: https://www.linkedin.com/in/warnerbiddle/

    41 分钟
  2. Lavakumar Karyampudi: Building early-phase CGT infrastructure for translational success

    8月12日

    Lavakumar Karyampudi: Building early-phase CGT infrastructure for translational success

    In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Lavakumar (Kumar) Karyampudi, Senior Director of Cell Therapies at Moffitt Cancer Center, to discuss how academic institutions are evolving to meet the demands of early-phase CGT trials. Kumar shares how Moffitt is building flexible, end-to-end infrastructure that supports the full development cycle – from translational research to GMP manufacturing. Together, they explore how tighter integration between scientists, clinicians, and operational teams can accelerate first-in-human trials, why academic centres play a crucial role in advancing CGTs, and how the right partnerships can extend institutional capabilities. Connect with Kumar: https://www.linkedin.com/in/lavakumar-karyampudi/

    1 小时
  3. Henrik Andersen: How smart planning helps CGT scale further, faster

    7月15日

    Henrik Andersen: How smart planning helps CGT scale further, faster

    In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Henrik Andersen, former SVP and Head of Cell Therapy Technology Development at Bristol Myers Squibb, to explore how early planning, automation, and economic discipline can help scale the impact of cell therapies. Henrik draws on his experience in both biologics and cell therapy to discuss how platform thinking, target product profiles, and cost-of-goods modelling can be applied earlier in development. Together, they reflect on the pitfalls of rushing to clinic without a viable manufacturing strategy, the shift in investor expectations, and why adapting lessons from biologics could help CGT companies avoid costly detours on the path to commercial success. Connect with Henrik

    54 分钟
  4. Arsalan Arif: Investor confidence in advanced therapies is critical for long-term success

    7月1日

    Arsalan Arif: Investor confidence in advanced therapies is critical for long-term success

    In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Arsalan Arif, founder of Endpoints News, for a wide-ranging conversation on the business of biotech. From his early days bootstrapping a media company to Endpoints’ recent partnership with the Financial Times, Arsalan shares his journey and reflections on what it takes to build trust in an evolving industry. Together, they unpack today’s cell and gene therapy landscape, where clinical success alone isn’t enough. Arsalan offers his perspective on investor sentiment, why scaling remains the biggest challenge in CGT, and how economic models, not efficacy, will shape the next chapter of growth. Learn more about Arsalan: https://www.linkedin.com/in/arsalanarif/

    48 分钟
  5. Julie Allickson: How early automation strategies reduce costs and improve patient access

    6月17日

    Julie Allickson: How early automation strategies reduce costs and improve patient access

    In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Dr. Julie Allickson, Chief Technology Officer for Mayo Clinic's Center for Regenerative Biotherapeutics. With over 30 years pioneering regenerative medicine - from early bone marrow transplant programs to today's cutting-edge cell and gene therapies - Julie shares her journey and insights on translating innovative therapies from discovery to clinical impact. Together, they explore how academic medical centers are evolving to bridge the gap between research and commercialization through integrated manufacturing capabilities, multi-site clinical trials, and strategic partnerships. Julie discusses Mayo Clinic's approach to managing 30+ clinical trials across three sites, the critical role of automation and AI in reducing costs and improving scalability, and why thinking about commercial viability early in development is essential widespread patient access. Learn more: https://www.linkedin.com/in/julie-g-allickson-phd-76129062/

    49 分钟
  6. Aaron Vernon: Designing scalable cell therapy manufacturing from day one (part 2)

    6月3日

    Aaron Vernon: Designing scalable cell therapy manufacturing from day one (part 2)

    In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes back Aaron Vernon, Chief Manufacturing Officer at Quell Therapeutics, for the second part of the discussion on building robust and scalable cell therapy manufacturing systems. Together, they explore how applying principles like the Theory of Constraints, designing smarter facility layouts, and implementing digital systems can reduce bottlenecks and improve throughput. Aaron brings over 20 years of experience leading manufacturing, engineering and supply chain operations across biologics and cell therapy. We’re grateful for his insights as the industry works to deliver more consistent, cost-effective therapies to patients at scale. Learn more: https://www.linkedin.com/in/aaronvernon/

    44 分钟
  7. Aaron Vernon: Designing scalable cell therapy manufacturing from day one (part 1)

    5月23日

    Aaron Vernon: Designing scalable cell therapy manufacturing from day one (part 1)

    In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Aaron Vernon, Chief Manufacturing Officer at Quell Therapeutics, for a two-part discussion on building robust and scalable cell therapy manufacturing systems. Together they explore how applying principles like the Theory of Constraints, designing smarter facility layouts, and implementing digital systems can reduce bottlenecks and improve throughput. Aaron brings over 20 years of experience leading manufacturing, engineering and supply chain operations across biologics and cell therapy. We’re grateful for his insights as the industry works to deliver more consistent, cost-effective therapies to patients at scale. Learn more: https://www.linkedin.com/in/aaronvernon/

    57 分钟
  8. Amritha Jaishankar: Advancing data integration and decentralized manufacturing for CGT access

    2024/11/25

    Amritha Jaishankar: Advancing data integration and decentralized manufacturing for CGT access

    In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Amritha Jaishankar, Executive Director of the Cell and Gene Therapy Center at IQVIA, to discuss how data integration and decentralized manufacturing are reshaping access to advanced therapies. Amritha shares her insights on how to overcome systemic challenges in cell and gene therapy, including data silos, workforce gaps, and manufacturing inefficiencies. Together, they explore the transformative potential of community sites, digital platforms and collaborative partnerships in driving scalability, improving affordability of CGTs, and expanding their access worldwide. Learn more: https://www.linkedin.com/in/amrithajaishankar/

    51 分钟
查看全部 49 集

关于

Ori Spotlight covers the latest in cell and gene therapy. Jason C. Foster, Ori Biotech CEO will be talking to leaders from across the industry to find out more about how we can break down the barriers and seize the opportunities to make sure that every patient has access to life-changing treatments. Connect with Ori Biotech to learn more about partnering to pioneer innovative technologies in CGT manufacturing that bring CGT products to market at commercial scale at decreased costs while increasing throughput and improving quality: www.oribiotech.com/connect

信息

  • 创作者
    Ori Biotech
  • 活跃年份
    2021年 - 2025年
  • 单集
    49
  • 分级
    儿童适宜
  • 版权
    © Ori Biotech
  • 节目网站
    Ori Spotlight